Product Images Deferasirox

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Deferasirox NDC 45963-455 by Actavis Pharma, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

9c6b4e1d-figure-01 - image 1

9c6b4e1d-figure-01 - image 1

250 - image 10

250 - image 10

Deferasirox Tablets for oral suspension are dispensed in a container with 30 tablets. The pharmacist should accompany each patient with a medication guide. The dosage must be indicated in the package insert. The tablets must be dispersed in water and cannot be chewed or swallowed whole. A tight, light-resistant container must be dispensed to store the tablets at a controlled temperature between 15-30°C. The medicine is manufactured by Teva Pharmaceuticals and the lot number is 45963-455-30. The text also includes a serial coding area. Print Medication Guides are available on the tevausa.com/medguides website.*

500 - image 11

500 - image 11

This is a description of a medication named Deferasirox Tablets that come in a bottle of 30 tablets with 500mg of the active ingredient. It provides instructions to disperse the tablets in water before ingestion, rather than swallowing or chewing them whole. The medication guide should be provided to patients by a pharmacist. The tablets should be kept in a light-resistant container at a temperature of 25°C (77°F) and protected from moisture. The medication should be kept out of reach of children. The medication is manufactured by Teua Pharmaceuticals in Parsippany, NJ. The code NDC 45963-456-30 identifies this medication product.*

9c6b4e1d-figure-02 - image 2

9c6b4e1d-figure-02 - image 2

9c6b4e1d-figure-03 - image 3

9c6b4e1d-figure-03 - image 3

9c6b4e1d-figure-04 - image 4

9c6b4e1d-figure-04 - image 4

9c6b4e1d-figure-05 - image 5

9c6b4e1d-figure-05 - image 5

This data appears to be related to the study of liver iron content and serum ferritin levels. The text includes information on dosages of Deferasirox Tablets, which seems to be a medication for iron-overload conditions such as hereditary hemochromatosis. The has also captured some numerical figures indicating the change in serum ferritin and liver iron content (in mg Felg dw). However, the meaning behind the first two lines of text is not clear.*

9c6b4e1d-figure-06 - image 6

9c6b4e1d-figure-06 - image 6

9c6b4e1d-figure-07 - image 7

9c6b4e1d-figure-07 - image 7

9c6b4e1d-figure-08 - image 8

9c6b4e1d-figure-08 - image 8

125 - image 9

125 - image 9

Deferasirox Tablets for Oral Suspension used to remove excess iron from the body. It is a prescription-only medication containing 30 tablets, each tablet contains Deferasirox 125mg. The pharmacist must dispense the medication guide to every patient. The tablets should be dispersed in water or apple juice before ingestion to consume them. The medication should be kept in a light-resistant container within the temperature range from 15 to 30°C. Teua Pharmaceuticals manufactures the medication. The lot number and expiration date are indicated on the packaging. Serialization Coding Area in also provided.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.